Annual accounts receivable:
$129.19M+$78.09M(+152.84%)Summary
- As of today (June 23, 2025), TGTX annual accounts receivable is $129.19 million, with the most recent change of +$78.09 million (+152.84%) on December 31, 2024.
- During the last 3 years, TGTX annual accounts receivable has risen by +$127.80 million (+9200.58%).
- TGTX annual accounts receivable is now at all-time high.
Performance
TGTX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$190.12M+$60.94M(+47.17%)Summary
- As of today (June 23, 2025), TGTX quarterly accounts receivable is $190.12 million, with the most recent change of +$60.94 million (+47.17%) on March 1, 2025.
- Over the past year, TGTX quarterly accounts receivable has increased by +$125.14 million (+192.57%).
- TGTX quarterly accounts receivable is now at all-time high.
Performance
TGTX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TGTX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +152.8% | +192.6% |
| 3 y3 years | +9200.6% | +10000.0% |
| 5 y5 years | - | - |
TGTX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TGTX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $190.12M(+47.2%) |
| Dec 2024 | $129.19M(+152.8%) | $129.19M(+11.6%) |
| Sep 2024 | - | $115.73M(+38.4%) |
| Jun 2024 | - | $83.61M(+28.7%) |
| Mar 2024 | - | $64.98M(+27.2%) |
| Dec 2023 | $51.09M(>+9900.0%) | $51.09M(+29.9%) |
| Sep 2023 | - | $39.32M(+124.9%) |
| Jun 2023 | - | $17.48M(+102.8%) |
| Mar 2023 | - | $8.62M(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $88.00K(-90.3%) |
| Mar 2022 | - | $903.00K(-35.0%) |
| Dec 2021 | $1.39M(>+9900.0%) | $1.39M(+0.4%) |
| Sep 2021 | - | $1.38M(+48.7%) |
| Jun 2021 | - | $931.00K(+20.8%) |
| Mar 2021 | - | $771.00K(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2002 | - | $501.70K(+159.9%) |
| Dec 2000 | $193.00K(-35.7%) | $193.00K(-35.7%) |
| Dec 1999 | $300.00K | $300.00K |
FAQ
- What is TG Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for TG Therapeutics?
- What is TG Therapeutics annual accounts receivable year-on-year change?
- What is TG Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for TG Therapeutics?
- What is TG Therapeutics quarterly accounts receivable year-on-year change?
What is TG Therapeutics annual accounts receivable?
The current annual accounts receivable of TGTX is $129.19M
What is the all time high annual accounts receivable for TG Therapeutics?
TG Therapeutics all-time high annual accounts receivable is $129.19M
What is TG Therapeutics annual accounts receivable year-on-year change?
Over the past year, TGTX annual accounts receivable has changed by +$78.09M (+152.84%)
What is TG Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of TGTX is $190.12M
What is the all time high quarterly accounts receivable for TG Therapeutics?
TG Therapeutics all-time high quarterly accounts receivable is $190.12M
What is TG Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, TGTX quarterly accounts receivable has changed by +$125.14M (+192.57%)